Cyprotex - News
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.

Result of AGM

Cyprotex PLC ("Cyprotex" or the "Company")

Results of Annual General Meeting

At the Annual General Meeting of Cyprotex (AIM:CRX), the drug discovery technology and information company, held today all resolutions were passed.

Copies of the approved resolutions will be submitted to the UK Listing Authority and will shortly be available for inspection at the UK Listing Authority's Document Viewing Facility, which is situated at:

Financial Services Authority
25 The North Colonnade
Canary Wharf
London E14 5HS
Tel: +44 (0) 20 7676 1000


For further information:
Cyprotex PLC

Dr Anthony Baxter, Chief Executive Officer
John Dootson, Chief Financial Officer
Tel: +44 (0) 1625 505 100
ir@cyprotex.com
www.cyprotex.com

Singer Capital Markets Ltd
Shaun Dobson
Claes Spång
Tel: +44 203 205 7500
www.singercm.com

Financial Dynamics
Tel: +44 (0) 20 7831 3113
Ben Brewerton / Ben Atwell / Mo Noonan
cyprotex@fd.com
www.fd.com

Contact us

News categories

Archives

Contact us to discuss your ADME Tox issues or request a quote

Telephone:
North America (East Coast): 888-297-7683
Europe: +44 1625 505100

 

or fill out the form below:

Please give details of the assays you are interested in. Where appropriate please specify one or more species (human, rat, mouse etc.), isoforms (CYP1A1,CYP1B1, etc) or other relevant details.

Close